1. Abboud, H, Probasco, J, Irani, SR, et al. Autoimmune encephalitis: proposed recommendations for symptomatic and long-term management. J Neurol Neurosurg Psychiatry 2021; 92: 897–907.
Google Scholar | Crossref2. Dalmau, J, Tüzün, E, Wu, H-y, et al. Paraneoplastic anti–N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007; 61: 25–36.
Google Scholar | Crossref | Medline3. Irani, SR, Gelfand, JM, Al-Diwani, A, et al. Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms. Ann Neurol 2014; 76: 168–184.
Google Scholar | Crossref | Medline4. Shin, YW, Lee, ST, Park, KI, et al. Treatment strategies for autoimmune encephalitis. Ther Adv Neurol Disord 2018; 11: 1756285617722347.
Google Scholar | SAGE Journals5. Titulaer, MJ, McCracken, L, Gabilondo, I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 2013; 12: 157–165.
Google Scholar | Crossref | Medline6. Lee, W-J, Lee, S-T, Byun, J-I, et al. Rituximab treatment for autoimmune limbic encephalitis in an institutional cohort. Neurology 2016; 86: 1683–1691.
Google Scholar | Crossref | Medline7. Nosadini, M, Mohammad, SS, Ramanathan, S, et al. Immune therapy in autoimmune encephalitis: a systematic review. Expert Rev Neurother 2015; 15: 1391–1419.
Google Scholar | Crossref | Medline8. Klettner, A, Herdegen, T. FK506 and its analogs – therapeutic potential for neurological disorders. Curr Drug Targets CNS Neurol Disord 2003; 2: 153–162.
Google Scholar | Crossref | Medline9. Konishi, T, Yoshiyama, Y, Takamori, M, et al. Long-term treatment of generalised myasthenia gravis with FK506 (tacrolimus). J Neurol Neurosurg Psychiatry 2005; 76: 448–450.
Google Scholar | Crossref | Medline10. Matsubara, S, Kondo, K, Sugaya, K, et al. Effects of tacrolimus on dermatomyositis and polymyositis: a prospective, open, non-randomized study of nine patients and a review of the literature. Clin Rheumatol 2012; 31: 1493–1498.
Google Scholar | Crossref | Medline11. Chen, B, Wu, Q, Ke, G, et al. Efficacy and safety of tacrolimus treatment for neuromyelitis optica spectrum disorder. Sci Rep 2017; 7: 831.
Google Scholar | Crossref | Medline12. Hirano, K, Aiba, H, Yano, M, et al. [Effect of tacrolimus in a case of autoimmune encephalitis]. No to Hattatsu 2007; 39: 436–439.
Google Scholar | Medline13. Shin, YW, Lee, ST, Shin, JW, et al. VGKC-complex/LGI1-antibody encephalitis: clinical manifestations and response to immunotherapy. J Neuroimmunol 2013; 265: 75–81.
Google Scholar | Crossref | Medline14. Graus, F, Titulaer, MJ, Balu, R, et al. A clinical approach to diagnosis of autoimmune encephalitis. The Lancet Neurology 2016; 15: 391–404.
Google Scholar | Crossref | Medline15. Cai, M-T, Lai, Q-L, Zheng, Y, et al. Validation of the Clinical Assessment Scale for Autoimmune Encephalitis: a multicenter study. Neurol Ther 2021; 10: 985–1000.
Google Scholar | Crossref | Medline16. Lim, J-A, Lee, S-T, Moon, J, et al. Development of the clinical assessment scale in autoimmune encephalitis. Ann Neurol 2019; 85: 352–358.
Google Scholar | Crossref | Medline17. van Coevorden-Hameete, MH, de Graaff, E, Titulaer, MJ, et al. Molecular and cellular mechanisms underlying anti-neuronal antibody mediated disorders of the central nervous system. Autoimmun Rev 2014; 13: 299–312.
Google Scholar | Crossref | Medline18. Carvajal-Gonzãlez, A, Leite, MI, Waters, P, et al. Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes. Brain 2014; 137(Pt8): 2178–2192.
Google Scholar | Crossref | Medline19. Kerschbaumer, A, Sepriano, A, Smolen, JS, et al. Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis. Ann Rheum Dis 2020; 79: 744–759.
Google Scholar | Crossref | Medline20. Broen, JCA, van Laar, JM. Mycophenolate mofetil, azathioprine and tacrolimus: mechanisms in rheumatology. Nat Rev Rheumatol 2020; 16: 167–178.
Google Scholar | Crossref | Medline21. Morteau, O, Blundell, S, Chakera, A, et al. Renal transplant immunosuppression impairs natural killer cell function in vitro and in vivo. PLOS ONE 2010; 5: e13294.
Google Scholar | Crossref | Medline22. Lancaster, E, Dalmau, J. Neuronal autoantigens–pathogenesis, associated disorders and antibody testing. Nat Rev Neurol 2012; 8: 380–390.
Google Scholar | Crossref | Medline23. Schneider-Gold, C, Hartung, HP, Gold, R. Mycophenolate mofetil and tacrolimus: new therapeutic options in neuroimmunological diseases. Muscle Nerve 2006; 34: 284–291.
Google Scholar | Crossref | Medline24. Lopez-Chiriboga, AS, Flanagan, EP. Diagnostic and therapeutic approach to autoimmune neurologic disorders. Semin Neurol 2018; 38: 392–402.
Google Scholar | Crossref | Medline25. Dalmau, J, Graus, F. Antibody-mediated encephalitis. N Engl J Med 2018; 378: 840–851.
Google Scholar | Crossref | Medline26. Gadoth, A, Pittock, SJ, Dubey, D, et al. Expanded phenotypes and outcomes among 256 LGI1/CASPR2-IgG-positive patients. Ann Neurol 2017; 82: 79–92.
Google Scholar | Crossref | Medline27. Gabilondo, I, Saiz, A, Galán, L, et al. Analysis of relapses in anti-NMDAR encephalitis. Neurology 2011; 77: 996–999.
Google Scholar | Crossref | Medline28. Tanaka, M, Kinoshita, M, Tanaka, K. Corticosteroid and tacrolimus treatment in neuromyelitis optica related disorders. Mult Scler 2015; 21: 669–669.
Google Scholar | SAGE Journals29. Morita, Y, Sasae, Y, Sakuta, T, et al. Efficacy of low-dose tacrolimus added to methotrexate in patients with rheumatoid arthritis in Japan: a retrospective study. Mod Rheumatol 2008; 18: 379–384.
Google Scholar | Crossref | Medline30. Singh, N, Bonham, A, Fukui, M. Immunosuppressive-associated leukoencephalopathy in organ transplant recipients. Transplantation 2000; 69: 467–472.
Google Scholar | Crossref | Medline31. Shapiro, R, Nalesnik, M, McCauley, J, et al. Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation 1999; 68: 1851–1854.
Google Scholar | Crossref | Medline32. Xu, X, Lu, Q, Huang, Y, et al. Anti-NMDAR encephalitis: a single-center, longitudinal study in China. Neurol Neuroimmunol Neuroinflamm 2020; 7: e633.
Google Scholar | Crossref